The Institute of Medicine (USA) report found little solid evidence that testosterone replacement therapy provides benefits. Washington (USA) – Many doctors are still haunted by the crisis erupted over the use of estrogen and progestin for the management of menopause, when the Womens Health Initiative found that hormone use increases cancer risk breast cancer in women. This was the conclusion that has shaken many doctors and patients – and the practice of medicine. One thing is certain: no one wants to repeat the experiment with another hormone, and the population of another.And so the final questions about testosterone therapy.
On 12 November a group of the Institute of Medicine recommends that small studies to determine the benefits of testosterone replacement therapybefore taking a straight, long-term clinical trial takes place. It is a recommendation that has left some doctors want more. I think it would be nice if we could have started something equivalent for womens health initiative very quickly, said John Morley, MD, professor of geriatrics at Saint Louis University School of Medicine. Within five to 10 years it takes to conduct the study, testosterone replacement industry is set to continue its rapid growth.Then we will see an area U.S. $ 2.9 billion and a lot of prescriptions, said Dr. Morley. Instead, I think we also see a lot of small studies, some positive and some negative, but what is not and desperately need to know is that there are bad side effects?
IOM: the first small tests to examine the available studies, said theIOM panel to the small number of placebo-controlled trials that testosterone treatment were investigated in dismay. We identified 31 studies that older men and one lasted over a year. Most had fewer than 50 participants, said the panel chairman Dan Blazer, MD, PhD, MPH, professor of psychiatry and behavioral sciences at Duke University Medical Center in Durham, North Carolina, the committee decided that should the first studies
Pages:  2 3